VEN+DAC+Bu2Flu4 vs Bu2Flu5 Conditioning Regimen for Elderly Myeloid Malignancies Undergoing Allo-HSCT

NCT07052422 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

NOT_YET_RECRUITING

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Older Patients
Myeloid Malignancies
Conditioning
Hematopoietic Stem Cell Transplantation (HSCT)

Interventions

DRUG: Venetoclax (VEN)
DRUG: Decitabine (DAC)
DRUG: Busulfan (Bu)
DRUG: Fludarabine (Flu)
DRUG: Fludarabine (Flu)

Sponsor

Nanfang Hospital, Southern Medical University